Instructions: Use the pencil icon in the top right to edit the form below. ↗️ Remember to push UPDATE when you are done to save your work.
Statin Initiation Goals:
Received Prescription - ASCVD (Cohort): goal of 40% of those who come in for a f/u visit
Received Prescription - LDL ≥190 mg/DL (Cohort): goal of 30% of those who come in for a f/u visit
Received Prescription - Diabetes and LDL 70-189 mg/DL (Cohort): goal of 45% of those who come in for a f/u visit
Important Health Center Context Fill out this section during your planning process | |
---|---|
Internal Characteristics | |
What are the characteristics of your health center? (rural/urban; other demographic variables)? |
|
What are the infrastructure characteristics of your health center (use of the expanded care team, culture)? |
|
How do interventions and/or workflows need to be adapted to ensure health equity? |
|
How complex are the patient interventions to implement (e.g., perceived difficulty of implementation, reflected by duration, scope, radicalness, disruptiveness, and number of steps required)? |
|
What are key characteristics of the participating setting(s)? |
|
External Characteristics | |
What external or environmental supports or threats are there? |
|
Plan | Actual |
Describe Intervention Chosen intervention: Statin Initiation and Follow Up Plan for intervention:
| Chosen Intervention: Date when implemented: Updates: 1. 12/6 - found that patients were not always able to come into clinic to be assessed for statin therapy - can assess in other ways. Decided the providers/MAS partnered to determine which patients missed or did not come into appt. Reached out via telemedicine- extremely successful. Leon took time daily to provide with guidelines - whenever working in clinic will review patient population and ask if they could benefit from statin therapy and then see if MA could recall pt. Statin therapy assessment - ensuring pts dont fall through the cracks if no one follows up. if #2 Leon reviewed list and there was a gap in the process, Leon would call - have great relationships with providers can see actual appointments in chart #3 see above - ensuring they are recommending statin therapy. Many times patient who providers consider well managed (A1c). Have an opportunity for provider to work directly with patients |
Reach (#/% patients – or providers, for provider-facing interventions – who participated in intervention) | |
Reach of implementers/providers? Planned:
| Reach of implementers/providers? Actual: |
Reach of patients? Planned:
| Reach of patients? Actual: |
Efficacy (Impact of intervention on important outcomes) | |
How will you measure that your intervention is working?
| Were you able to accurately measure how your intervention was working? |
What outcomes do you expect?
| What outcomes have you seen? |
How will you ensure your intervention will be effective for your target population?
| Did your intervention reach the target population? |
What unintended consequences or outcomes might there be? | What unintended outcomes did you experience? |
Adoption (#/% and representativeness of staff and sites who implemented the intervention) How did clinicians respond to interventions to intensify medication more rapidly/address therapeutic inertia? | |
Who will deliver the intervention (actually do the work)? Include staff and sites, if applicable.
| Who delivered the intervention? Did they have the skills and time needed to complete the intervention? |
How will you know if clinicians/care teams/sites used the intervention?
| What proportion of the planned staff/sites implemented the intervention? Were there any differences between care teams/sites who adopted the intervention best vs. others who did not (e.g., differences in staff types, capacity, etc.)? |
Implementation Fidelity (How closely the staff/sites followed the intervention design, delivered it as intended – also called fidelity to the intervention) | |
How will you know what adaptations or modifications were made during the intervention? | How did you track modifications during the intervention? |
What might be some of the possible obstacles to consistent implementation? | What were the barriers to consistent intervention implementation? |
What costs and resources (including time and burden, not just money) need to be considered? | What costs and resources (including time and burden, not just money) need to be considered? |
How closely did the staff/sites follow the intervention design and deliver as intended? Check all that apply:
Modifications made and other notes: | |
Maintenance (Extent to which intervention is part of routine practices and protocols) | |
What reinforcements will you put in place to sustain the intervention, if effective?
Explain: | What reinforcements did you put into place to sustain the intervention?
Explain: |
How will you spread your intervention and lessons learned? | How will you spread your intervention and lessons learned? |
What are likely modifications or adaptations that will need to be made to sustain the intervention over time (e.g., lower cost, different staff, reduced intensity, different settings)? |
Intervention #2 Plan | Intervention #2 Actual |
Describe Intervention Chosen intervention: Patient Outreach Plan for intervention:
| Chosen Intervention: Date when implemented: Updates: |
Reach (#/% patients – or providers, for provider-facing interventions – who participated in intervention) | |
Reach of implementers/providers? Planned: | Reach of implementers/providers? Actual: |
Reach of patients? Planned: | Reach of patients? Actual: |
Efficacy (Impact of intervention on important outcomes) | |
How will you measure that your intervention is working?
| Were you able to accurately measure how your intervention was working? |
What outcomes do you expect?
| What outcomes have you seen? |
How will you ensure your intervention will be effective for your target population? | Did your intervention reach the target population? |
What unintended consequences or outcomes might there be? | What unintended outcomes did you experience? |
Adoption (#/% and representativeness of staff and sites who implemented the intervention) How did clinicians respond to interventions to intensify medication more rapidly/address therapeutic inertia? | |
Who will deliver the intervention (actually do the work)? Include staff and sites, if applicable. | Who delivered the intervention? Did they have the skills and time needed to complete the intervention? |
How will you know if clinicians/care teams/sites used the intervention? | What proportion of the planned staff/sites implemented the intervention? Were there any differences between care teams/sites who adopted the intervention best vs. others who did not (e.g., differences in staff types, capacity, etc.)? |
Implementation Fidelity (How closely the staff/sites followed the intervention design, delivered it as intended – also called fidelity to the intervention) | |
How will you know what adaptations or modifications were made during the intervention? | How did you track modifications during the intervention? |
What might be some of the possible obstacles to consistent implementation? | What were the barriers to consistent intervention implementation? |
What costs and resources (including time and burden, not just money) need to be considered? | What costs and resources (including time and burden, not just money) need to be considered? |
How closely did the staff/sites follow the intervention design and deliver as intended? Check all that apply:
Modifications made and other notes: | |
Maintenance (Extent to which intervention is part of routine practices and protocols) | |
What reinforcements will you put in place to sustain the intervention, if effective?
Explain: | What reinforcements did you put into place to sustain the intervention?
Explain: |
How will you spread your intervention and lessons learned? | How will you spread your intervention and lessons learned? |
What are likely modifications or adaptations that will need to be made to sustain the intervention over time (e.g., lower cost, different staff, reduced intensity, different settings)? |
Version | Date | Comment |
---|---|---|
Current Version (v. 13) | Feb 27, 2024 14:40 | Antoinette Anwar |
v. 21 | Apr 18, 2024 18:00 | Antoinette Anwar |
v. 20 | Apr 18, 2024 17:27 | Antoinette Anwar |
v. 19 | Apr 16, 2024 13:24 | Antoinette Anwar |
v. 18 | Apr 16, 2024 13:18 | Antoinette Anwar |
v. 17 | Apr 15, 2024 21:28 | Antoinette Anwar |
v. 16 | Apr 15, 2024 21:25 | Antoinette Anwar |
v. 15 | Apr 15, 2024 18:31 | Antoinette Anwar |
v. 14 | Feb 27, 2024 18:52 | Chris Espersen |
v. 13 | Feb 27, 2024 14:40 | Antoinette Anwar |
v. 12 | Jan 11, 2024 16:10 | Antoinette Anwar |
v. 11 | Jan 05, 2024 18:38 | Lauren Becker |
v. 10 | Dec 21, 2023 15:21 | Antoinette Anwar |
v. 9 | Dec 06, 2023 18:43 | Chris Espersen |
v. 8 | Dec 06, 2023 14:37 | Antoinette Anwar |
v. 7 | Dec 06, 2023 14:31 | Antoinette Anwar |
v. 6 | Nov 08, 2023 13:59 | Antoinette Anwar |
v. 5 | Oct 28, 2023 00:05 | Antoinette Anwar |
v. 4 | Oct 24, 2023 18:38 | Antoinette Anwar |
v. 3 | Oct 24, 2023 18:09 | Antoinette Anwar |
v. 2 | Oct 13, 2023 18:40 | Lauren Becker |
v. 1 | Sept 18, 2023 20:31 | Lauren Becker |
Add Comment